1-5 of 5
Pietro Fabris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Clinical Trials & Observations
Renato Bassan, Orietta Spinelli, Elena Oldani, Tamara Intermesoli, Manuela Tosi, Barbara Peruta, Giuseppe Rossi, Erika Borlenghi, Enrico M. Pogliani, Elisabetta Terruzzi, Pietro Fabris, Vincenzo Cassibba, Giorgio Lambertenghi-Deliliers, Agostino Cortelezzi, Alberto Bosi, Giacomo Gianfaldoni, Fabio Ciceri, Massimo Bernardi, Andrea Gallamini, Daniele Mattei, Eros Di Bona, Claudio Romani, Anna Maria Scattolin, Tiziano Barbui, Alessandro Rambaldi
Journal: Blood
Blood (2009) 113 (18): 4153–4162.
https://doi.org/10.1182/blood-2008-11-185132
Published: 2009
Includes: Supplemental data
Journal Articles

Herpes Simplex Virus Encephalitis (HSE) after Allogeneic Hematopoietic Stem Cell Transplatation (alloHSCT): Impact of Early Diagnosis and Treatment on Outcome.

Irene M. Cavattoni, MD, Enrico Morello, M.D., Marco Casini, M.D., Norma Decaminada, M.D., Leonardo Pagani, M.D., Pietro Fabris, M.D., Sergio Cortelazzo, M.D.
Journal: Blood
Blood (2007) 110 (11): 5002.
https://doi.org/10.1182/blood.V110.11.5002.5002
Published: 2007
Journal Articles

Impact of Prophylaxis with Aerosolized Amphotericin-B Deoxycholate (d-AmB) on Respiratory Tract Invasive Fungal Infections (IFIs) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Enrico Morello, MD, Irene M. Cavattoni, M.D., Pietro Fabris, M.D., Silvia Coin, B.S.C., Barbara Amato, M.D., Vincenzo Cassibba, M.D., Marco Casini, M.D., Leonardo Pagani, M.D., Sergio Cortelazzo, M.D.
Journal: Blood
Blood (2007) 110 (11): 4986.
https://doi.org/10.1182/blood.V110.11.4986.4986
Published: 2007
Journal Articles

Minimal Residual Disease (MRD)-Oriented Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Results of Northern Italy Leukemia Group Study 09/00.

Renato Bassan, MD, Orietta Spinelli, BSc, Elena Oldani, BSc, Tamara Intermesoli, MD, Manuela Tosi, BSc, Barbara Peruta, BSc, Vittoria Guerini, BSc, Giuseppe Rossi, MD, Enrico Pogliani, MD, Eros Di Bona, MD, Pietro Fabris, MD, Agostino Cortelezzi, MD, Teodoro Chisesi, MD, Emanuele Angelucci, MD, Franco Leoni, MD, Fabio Ciceri, MD, Daniele Mattei, MD, Tiziano Barbui, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2007) 110 (11): 3497.
https://doi.org/10.1182/blood.V110.11.3497.3497
Published: 2007
Journal Articles

Minimal Residual Disease (MRD) and Risk-Oriented Therapy in Adult Acute Lymphoblastic Leukemia (ALL).

Renato Bassan, MD, Orietta Spinelli, BSc, Elena Oldani, BSc, Tamara Intermesoli, MD, Manuela Tosi, BSc, Giuseppe Rossi, MD, Enrico M. Pogliani, MD, Emanuele Angelucci, MD, Pietro Fabris, MD, Giorgio Lambertenghi-Deliliers, MD, Paola Polistena, MD, Eros Di Bona, MD, Fabio Ciceri, MD, Franco Leoni, MD, Claudia Minotto, MD, Daniele Mattei, MD, Maurizio Musso, MD, Tiziano Barbui, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2005) 106 (11): 1836.
https://doi.org/10.1182/blood.V106.11.1836.1836
Published: 2005